Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Connect Biopharma Holdings (CNTB) Operating Expenses (2024 - 2025)

Historic Operating Expenses for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to $17.7 million.

  • Connect Biopharma Holdings' Operating Expenses rose 1744.44% to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.9 million, marking a year-over-year increase of 3867.38%. This contributed to the annual value of $48.5 million for FY2024, which is 2978.89% down from last year.
  • Latest data reveals that Connect Biopharma Holdings reported Operating Expenses of $17.7 million as of Q3 2025, which was up 1744.44% from $13.5 million recorded in Q2 2025.
  • In the past 5 years, Connect Biopharma Holdings' Operating Expenses registered a high of $17.7 million during Q3 2025, and its lowest value of $10.3 million during Q4 2024.